Shares of Boston Scientific (BSX) fell sharply in premarket trading on Wednesday after the cardiac device maker reported better-than-expected Q3 2026 financials but lowered its full-year outlook, ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-10-28 05:01:19









